Knockdown of Axl receptor tyrosine kinase in osteosarcoma cells leads to decreased proliferation and increased apoptosis

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue 1, 2013, Pages 179-188

  Zhang, Y ^a   Tang, Y J ^a   Man, Y ^a   Pan, F ^a   Li, Z H ^a   Jia, Lian Shun ^a  

^a Zhabei District Central Hospital   (China)

Author keywords

AKT; Apoptosis; Axl receptor tyrosine kinase; Clinicopathology; Proliferation

Indexed keywords

AXL RECEPTOR TYROSINE KINASE; KI 67 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE B; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; PROTEIN TYROSINE KINASE; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CANCER SIZE; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; MALE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; ADULT; DOWN REGULATION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MTT ASSAY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME;

EID: 84881257216     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201302600117     Document Type: Article

References (25)

1. Ham SJ, Schraffordt Koops H, van der Graaf WT, van Horn JR, Postma L, Hoekstra HJ. Historical, current and future aspects of osteosarcoma treatment. Eur J Surg Oncol 1998; 24:584-600. (Pubitemid 28566909)
2. Lin F, Zheng SE, Shen Z, Tang LN, Chen P, Sun YJ, Zhao H, Yao Y. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma. Med Oncol 2011; 28:649-53.
3. Yang JL, Yang D, Cogdell D, et al. APEX1 gene amplification and Its Protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival. Technol Cancer Res Treat 2010; 9:161-69.
4. Tajima Y, Yamazaki K, Makino R, et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 2006; 12:6469-79. (Pubitemid 44799720)
5. Korshunov VA. Axl-dependent signaling: a clinical update. Clin Sci (Lond) 2012; 122:361-8.
6. Ito M, Nakashima M, Nakayama T, et al. Expression of receptor-type tyrosine kinase, Ax1, and its ligand, Gas6, in pediatric thyroid carcinomas around chernobyl. Thyroid 2002; 12:971-5. (Pubitemid 35404131)
7. Sun WS, Fujimoto J, Tamaya T. Clinical implications of coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine leiomyoma. Mol Hum Reprod 2003; 9:701-7. (Pubitemid 37483957)
8. Green J, Ikram M, Vyas J, et al. Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours. Br J Cancer 2006; 94:1446-51. (Pubitemid 43772279)
9. Sun W, Fujimoto J, Tamaya T. Coexpression of Gas6/Axl in human ovarian cancers. Oncology 2004; 66:450-7. (Pubitemid 39370236)
10. Li Y, Ye X, Tan C, et al. Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene 2009; 28:3442-55.
11. Koorstra JB, Karikari CA, Feldmann G, Bisht S, Rojas PL, Offerhaus GJ, Alvarez H, Maitra A. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target. Cancer Biol Ther 2009; 8:618-26.
12. Wimmel A, Glitz D, Kraus A, Roeder J, Schuermann M. Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion. Eur J Cancer 2001; 37:2264-74. (Pubitemid 33001299)
13. Sainaghi PP, Castello L, Bergamasco L, Galletti M, Bellosta P, Avanzi GC. Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor. J Cell Physiol 2005; 204:36-44. (Pubitemid 40776804)
14. Mc Cormack O, Chung WY, Fitzpatrick P, et al. Growth arrest-specific gene 6 expression in human breast cancer. Br J Cancer 2008; 98:1141-6. (Pubitemid 351399805)
15. van Ginkel PR, Gee RL, Shearer RL, et al. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res 2004; 64:128-34. (Pubitemid 38114090)
16. Hutterer M, Knyazev P, Abate A, et al. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin Cancer Res 2008; 14:130-8. (Pubitemid 351377987)
17. Vajkoczy P, Knyazev P, Kunkel A, et al. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci USA 2006; 103:5799-804.
18. Ye X, Li Y, Stawicki S, Couto S, et al. An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies. Oncogene 2010; 29:5254-64.
19. Rankin EB, Fuh KC, Taylor TE, et al. AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Res 2010; 70:7570-9.
20. Hotfilder M, Sondermann P, Senss A, van Valen F, Jürgens H, Vormoor J. PI3K/AKT is involved in mediating survival signals that rescue Ewing tumor cells from fibroblast growth factor 2-induced cell death. Br J Cancer 2005; 92:705-10. (Pubitemid 40460607)
21. Tsubaki M, Yamazoe Y, Yanae M, et al. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma. Cytokine 2011; 54:100-107.
22. Sawabu T, Seno H, Kawashima T, et al. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog 2007; 46:155-64.
23. Tsimaratou K, Kletsas D, Kastrinakis NG, et al. Evaluation of claspin as a proliferation marker in human cancer and normal tissues. J Pathol 2007; 211:331-9. (Pubitemid 46172709)
24. Ethier C, Tardif M, Arul L, Poirier GG. PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent. PLoS One 2012; 7:e47978.
25. Zhang J, Zhang QY, Fu YC, et al. Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo. Technol Cancer Res Treat 2009; 8:467-78.